Clinical Trial Update: Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nivolumab alone or in combination with ipilimumab in patients with advanced or unresectable uterine leiomyosarcoma; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Unresectable Leiomyosarcoma
• Uterine Leiomyosarcoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2020-05-12